The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 25, 2005

Filed:

Oct. 26, 2001
Applicants:

Elisabeth Buchdunger, Neuenburg, DE;

Renaud Capdeville, Riedesheim, FR;

George Daniel Demetri, Brookline, MA (US);

Sasa Dimitrijevic, Habsheim, FR;

Brian Jay Druker, Portland, OR (US);

Jonathan A. Fletcher, Brookline, MA (US);

Michael C. Heinrich, Lake Oswego, OR (US);

Heikki Joensuu, Helsinki, FI;

Sandra Leta Silberman, Randolph, NJ (US);

David Tuveson, Berwyn, PA (US);

Inventors:

Elisabeth Buchdunger, Neuenburg, DE;

Renaud Capdeville, Riedesheim, FR;

George Daniel Demetri, Brookline, MA (US);

Sasa Dimitrijevic, Habsheim, FR;

Brian Jay Druker, Portland, OR (US);

Jonathan A. Fletcher, Brookline, MA (US);

Michael C. Heinrich, Lake Oswego, OR (US);

Heikki Joensuu, Helsinki, FI;

Sandra Leta Silberman, Randolph, NJ (US);

David Tuveson, Berwyn, PA (US);

Assignees:

Novartis AG, Basel, CH;

Dana-Farber Cancer Institute, Inc., Boston, MA (US);

Oregon Health & Science University, Portland, OR (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K031/497 ;
U.S. Cl.
CPC ...
Abstract

4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of the formula Ior a pharmaceutically acceptable salt thereof can be used in the treatment of gastrointestinal stromal tumours.


Find Patent Forward Citations

Loading…